Dogwood Therapeutics, Inc.
DWTX
$4.90
$0.102.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -61.87% | 195.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.27% | 227.75% | |||
| Operating Income | 41.27% | -227.75% | |||
| Income Before Tax | -38.90% | -238.86% | |||
| Income Tax Expenses | 38,200.00% | -- | |||
| Earnings from Continuing Operations | -41.37% | -238.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.37% | -238.84% | |||
| EBIT | 41.27% | -227.75% | |||
| EBITDA | 41.47% | -- | |||
| EPS Basic | -34.36% | -206.18% | |||
| Normalized Basic EPS | 45.89% | -187.11% | |||
| EPS Diluted | -34.36% | -206.18% | |||
| Normalized Diluted EPS | 45.89% | -187.11% | |||
| Average Basic Shares Outstanding | 10.00% | 18.03% | |||
| Average Diluted Shares Outstanding | 10.00% | 18.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||